9
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Relationship of Renal Histopathological Lesions to Immunoglobulin Classes and Complement Fixation of Anti-Native DNA Antibodies in Systemic Lupus Erythematosus

, , , , , & show all
Pages 209-214 | Received 28 Dec 1981, Published online: 12 Jul 2009
 

Abstract

The relationship of renal immunohisto-pathological lesions to the immunoglobulin classes (Ig) and complement fixation (CF) of anti-native DNA antibodies (anti-nDNA) in sera was studied in 20 patients with systemic lupus erythematosus (SLE) on whom renal biopsy was performed. The Ig classes and CF of anti-nDNA were assessed by the indirect immunofluorescent and complement fixation methods employing kinetoplasts of Crithidia luciliae as substrate. The histopathologically active lesions of lupus nephritis showed a significant correlation with the IgG and complement fixation of anti-native DNA antibodies in sera. IgM anti-nDNA superiority was not necessarily observed in patients with inactive histological lesions, but rather in those with thickening of the glomerular basement membrane. The granular deposits of immunoglobulin or complement in the renal glomeruli showed a significant correlation with the presence of IgG and CF of anti-nDNA in sera, while the deposition of C3 in the glomeruli also showed a significant correlation with the CF of anti-nDNA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.